QuidelOrtho looks to sell testing unit as PE circles healthcare companies



Diagnostic company’s shares are down 90% since its rapid antigen tests were the first to be approved for Covid-19


Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top